This website has been developed and fully funded by Bayer plc for a UK audience only.
Disclaimer and side effect reporting information can be found at the bottom of the page.

MENOPAUSE

INTRODUCTION

Women. We navigate a lifetime of changes in our bodies. From the first period to the years beyond menopause, these phases are a normal part of our lives.

But what happens when these "normal" changes start to impact our daily routines, our relationships,
and our well-being?

Losing interest in intimacy with our partners? It’s just a sign of getting older. Dealing with intense hot flushes, sleepless nights, and mood swings that make us feel like strangers in our own bodies? Welcome to menopause. It’s all just "normal".

Does this sound familiar?
It shouldn’t. WOMEN | Bayer believes that if enduring menopause symptoms is holding you back, it’s anything but "normal".

DISCOVER MORE

It might not seem like it, but these issues are more common than you realise. During perimenopause, many women notice a drop in their sexual desire which can affect their relationships and self-esteem. Many women experience debilitating menopausal symptoms, such as hot flushes, night sweats and sleep disturbance. Up to half of them are left to endure the symptoms, often feeling unheard. Experiencing symptoms of menopause is a normal part of life, but suffering in silence is not, and women should proactively look for solutions.

PERIMENOPAUSE

A lowered libido could be a sign of perimenopause, but you needn’t feel unfulfilled. It’s a symptom with treatment options.

MENOPAUSE

You don’t have to slow your life down when menopause happens. The symptoms have treatment options.

PP-UN-WHC-GB-0259 June 2025

    • 1
      Harper JC, Phillips S, Biswakarma R, Yasmin E, Saridogan E, Radhakrishnan S, C Davies M, Talaulikar V. An online survey of perimenopausal women to determine their attitudes and knowledge of the menopause. Womens Health (Lond). 2022 Jan-Dec;18:17455057221106890. doi: 10.1177/17455057221106890. PMID: 35758176; PMCID: PMC9244939.
    • 2
      Davis SR, Jane F. Sex and perimenopause. Aust Fam Physician. 2011 May;40(5):274-8. PMID: 21597543.
    • 3
      Nappi RE, Kroll R, Siddiqui E, et al. Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden [published correction appears in Menopause. 2022 Jun 01;29(6):759. doi: 10.1097/GME.0000000000001996]. Menopause. 2021;28(8):875-882. Published 2021 May 24. doi:10.1097/GME.0000000000001793.
    • 4
      Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation. Obstet Gynecol Clin North Am. 2011;38(3):489-501. doi:10.1016/j.ogc.2011.05.006.
    • 5
      Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health. 2006;96(7):1226-1235. doi:10.2105/AJPH.2005.066936.
    • 6
      Salari N, Hasheminezhad R, Hosseinian-Far A, et al. Global prevalence of sleep disorders during menopause: a meta-analysis. Sleep Breath 27, 1883–1897 (2023). https://doi.org/10.1007/s11325-023-02793-5.
    • 7
      DePree B, Shiozawa A, King D, et al. Association of menopausal vasomotor symptom severity with sleep and work impairments: a US survey. Menopause. 2023;30(9):887-897. doi:10.1097/GME.0000000000002237.
    • 8
      Yu Q, Chae HD, Hsiao SM, et al. Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause. Menopause. 2022;29(5):553-563. Published 2022 May 1. doi:10.1097/GME.0000000000001949.
    • 9
      Martin-Key NA, Funnell EL, Spadaro B, et al. Perceptions of healthcare provision throughout the menopause in the UK: a mixed-methods study. npj Womens Health 1, 2 (2023). https://doi.org/10.1038/s44294-023-00002-y.